Interpace Biosciences, Inc.
IDXG
Revenue
12.41M
▲116.00k▲0.9435%
3 Months ChangeAssets
14.79M
▲753.00k▲5.36%
3 Months ChangeLiabilities
17.01M
▼-1.03M▼-5.72%
3 Months ChangeFree Cash Flow
-86.00k
▼-1.15M▼-108.05%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-15
Form 8-K
ID: 0001493152-24-041144
2024-08-08
Form 10-Q
ID: 0001493152-24-030772
2024-08-02
Form 8-K
ID: 0001493152-24-030102
2024-05-09
Form 8-K
ID: 0001493152-24-018465
2024-05-09
Form 10-Q
ID: 0001493152-24-018432
2024-03-13
Form 8-K
ID: 0001493152-24-009737
2023-12-12
Form 8-K
ID: 0001493152-23-044550
2023-11-16
Form 8-K
ID: 0001493152-23-041662
2023-11-08
Form 8-K
ID: 0001493152-23-039945
2023-11-08
Form 10-Q
ID: 0001493152-23-039909